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Abstract
Aim: Based on the classical principles, to determine the optimal conditions for centrifugation, PRP harvesing (platelet-rich 
plasma). To conduct a quantitative assessment of the substrate obtained under different conditions of centrifugation.
Materials and methods. Based on the basic principles of obtaining platelet-rich plasma (PRP) by centrifuging in containers 
with an anticoagulant followed by phase separation to obtain the final substrate, the efficiency of the technique under the conditions 
of single and double centrifugation as well as under different conditions of acceleration and centrifugation was evaluated.
Blood for follow-up was collected from 20 healthy volunteers (11 men, 9 women) average 25.3±4.1 in syringes of LuerLock 
design with ACD-A anticoagulant solution, and centrifuged. Centrifugation was carried out under controlled conditions using a 
centrifuge with rotating bowls of the rotor. Centrifugation was performed at an acceleration of 100–400 g in time intervals up to 
20 minutes. Activation of the substrate was performed with calcium chloride solution.
Quantitative evaluation of platelets of whole blood and the final substrate of PRP was carried out with a semi-automatic 
analyzer.
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Results. The obtained results demonstrate the maximum level of harvesting efficiency when performing double centrifu-
gation in the 150g × 15 min+250g × 10 min mode. Subject to this centrifugation protocol, it is possible to obtain a substrate that 
complies with the standardized requirements for PRP.
The maximum level of an increase in the number of platelets in the substrate in comparison with whole blood is determined 
at the level of ×4.36 with concentration (volume reduction) ×5 in comparison with the volume of whole blood. 
Conclusions. This study demonstrated the advantage of double centrifuging modes over single modes.
According to the results of the study, it was possible to determine the conditions for an optimal double-centrifugation mode 
(acceleration and duration), which allows us to achieve the most efficient concentration of the substrate.
Keywords: platelet rich plasma, platelets, red blood cells, centrifugation, syringe, harvesing, acceleration.
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1. Introduction
Platelet-rich plasma platelet-based products (platelets-rich plasma, PRP) have been widely 
introduced into clinical practice due to the pronounced stimulating effect of the substrate [1, 2]. The 
autologous nature of the substrate is important, which almost completely eliminates the risk of im-
munological reactions and infectious and transplant complications [3, 4]. The high efficacy as well 
as the safety of platelet-rich plasma products (PRP) ensured its considerable popularity in dental 
surgery, as evidenced by significant number of publications in this field [5, 6]. Also, the enormous 
amount of work demonstrates the effectiveness of plasma-rich platelets in orthopedics for sports 
injuries [7, 8]. In plastic, reconstructive surgery, cosmetology, PRP is applicable for the purpose 
of correcting skin changes, including number and age [9, 10], as well as modifications of ischemic 
tissues during procedures related to the transplantation of flaps, fat graft [11, 12]. Also products 
based on PRP are used in the practice of cardiovascular, neurosurgeons, urologists, ginecologists 
[13, 14]. Despite the fact that the safety of the substrate does not cause doubts according to the over-
whelming majority of authors, the question remains about the observed lack of effectiveness as well 
as varying degrees of severity of the stimulating effect in solving similar problems according to 
various authors [15, 16]. A significant number of ready-made solutions proposed by manufacturers 
for obtaining plasma enriched with platelets, according to the results of application, according to 
the instructions, does not correspond to the expected declared results, which is stated in the works 
of some authors [17, 18]. Thus at this stage it is impossible to single out a single optimal method of 
harvesting as the gold standard for the implementation of the PRP procedure [19].
According to the classical principles of the procedure for obtaining platelets-rich plasma: the 
patient’s whole blood is collected in a container with an anticoagulant, which is subsequently subject-
ed to centrifugation [20]. Various containers are available on the market with differing principles of 
phase separation after centrifugation. At the same time, with similar designs of test tubes, contain-
ers, different manufacturers recommended different centrifuging modes: at different acceleration, of 
different duration. In some cases, one-step centrifugation is recommended, which contradicts other 
recommendations stating the higher efficiency of the double centrifugation mode [19, 21].
Kits with a gel separator of fractions of the RegenLab type (Switzerland) are difficult to 
work with, have a significant drawback associated with the high cost of consumables, and also 
demonstrate low efficiency in quantifying the final substrate. Another option for PRP production 
systems is kits with containers of an improved design, which simplifies the procedure for selecting 
separated phases, thus, to a lesser extent, the procedure depends on the skills of the contractor, but 
often such solutions are expensive. A more common option is kits based on classic PRGF EndoRet 
test tubes (PlasmaRichinGrowthFactors) from Biotechnology Institute, Spain, but this technology 
has the disadvantage of certain skill requirements due to the complexity of manual phase selection 
after centrifugation. Also applicable are techniques based on the use of containers that are securely 
and hermetically sealed for injection with the subsequent selection of the separated phases by mov-
ing between the syringes. Such harvesting options are highly cost-effective, but require specific 
skills from the performer [20, 22].
In all versions, the main stage of harvesting will be the procedure of phase separation (eryth-
rocytes, thrombocytic layer, and plasma) by centrifugation. Determination of optimal conditions: 
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acceleration, centrifugation duration as well as comparison of two-stage and one-stage centrifuga-
tion in harvesting remain an urgent problem, which does not have an unambiguous universal solu-
tion. The determination of optimal conditions is especially important in centrifuging techniques 
using syringe containers.
2. Aim of the work
Determine the optimal conditions for centrifuging whole blood in order to obtain the pro-
duction of plasma enriched with platelets using a syringe container.
3. Materials and methods
The study was performed on the basis of the Center for Reconstructive and Reconstructive 
Medicine as well as the Department of Surgery No. 4 with a course of oncology at the Odessa Na-
tional Medical University in 2018–2019.
Blood for the study was collected from 20 healthy volunteers (11 men, 9 women) with an 
average age of 25.3±4.1. All volunteers did not complain and did not suffer from chronic diseases. 
The blood of each of the volunteers was collected in 4 syringes with a volume of 5 ml in which 
0.5 ml (10 % of the volume) of the anticoagulant CITRAT glucose solution A (ACD-A) was previ-
ously collected. In all cases, identical syringes with a LuerLock design connector were used. Sy-
ringes were closed with a Kombi-stopper congruent plug. Each syringe was adapted in size for the 
purpose of placing it in the rotor bowl by removing excess piston length and removing finger stops. 
The syringe container was placed in the thicket of the rotor and subjected to centrifugation under 
various conditions of acceleration and centrifugation duration. Simultaneously centrifugation of 
4 blood samples from various volunteers was performed. Centrifugation was performed under 
strictly controlled conditions of rotational speed, centrifugal acceleration, centrifugation time 
using a HettichRotofix 32a centrifuge (Germany), with a symmetrical rotor, into 4 rotary bowls 
adapted for Arthrex ACP containers.
In the group of studies with a single centrifugation, the syringe container was removed from 
the rotor bowl with manual sampling ⅕ the volume of the syringe (1 ml) – including the buffer 
layer supplemented with the base plasma layer. The separation of the separated phases was carried 
out by aspirating the contents through a three-way valve into another syringe of the same volume 
with removal of the plasma apical layer, and preservation of the main thrombocytic-leukocyte layer 
with the base plasma layer. The substrate has been investigated.
In the double centrifugation study group, the first stage of centrifugation was carried out in a 
similar way. After aspiration, a plasma layer with a buffer (thrombocytic-leukocyte) layer was sep-
arated from the erythrocyte layer by means of aspiration through a three-way tap, Diskofix C. The 
syringe after the first stage of centrifugation with separated erythrocyte layer was disposed of. The 
syringe into which plasma aspiration was carried out with the buffer layer was closed with a Kombis-
toper plug and similarly adapted to the dimensions of the rotor bowl for subsequent centrifugation, 
was installed vertically. The result of the second centrifugation is the resultant layer at the base of the 
syringe container (1 ml), which was selected by a similar procedure by aspiration through the three-
way disc Diskofix, with this procedure the excess volume over 1 ml of the resulting substrate was 
removed and also disposed of. The resulting substrate was examined. The strict condition was that the 
positioning of the syringe containers should be vertical when selecting the separated layers.
Centrifugation was performed with centrifugal acceleration of 100 g, 150 g, 200 g for 
10 minutes, 15 minutes. Such initial parameters were determined empirically based on the experi-
ence of using the proposed technique earlier as well as data from other authors.
All studies were performed at a stable temperature of about 17 °C, with a humidity of 55 %.
Estimation of the platelet count of whole blood and the obtained PRP substrate was carried 
out using a Micro-CC 20 semi-automatic hematology analyzer (HTI, USA). The following indica-
tors were determined in all of the examined samples of whole blood and the resulting substrate; the 
results were analyzed: platelet count.
Statistical analysis: data were analyzed using Statistica 13.3 software. Values are expressed 
as mean±standard deviation. Analysis between groups with continuous data: single and double 
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centrifugation was performed using Student’s t-test and chi-square test. Pearson’s correlation anal-
ysis was performed to analyze linear correlations between variables. P<0.05 was considered sta-
tistically significant. The quantitative criteria that were determined were: PRP concentration effi-
ciency, platelet multiplication factor. The formulas for their calculation are given below. Analyzing 
the concentration of erythrocytes and leukocytes in the PRP substrate, it is possible to indirectly 
judge the effectiveness of the separation of the buffer layer and the “purity” of the final substrate.
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9
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Analyzing the concentration of erythrocytes and leukocytes, it is possible to indirectly 
judge the effectiveness of the separation of the buffer layer.
4. Results 
Table 1 shows data on the subjects, demonstrated quantitative indicators of hematological 
analysis. Both groups of research: a group of one-stage centrifugation, a group of double centrifu-
gation demonstrates a high level of sample homogeneity. The level of P value is given in the table 
(Table 1).
Table 1
Information about the group of the studied samples (in 20 patients 80 blood samples were collected)
Criterion Single centrifugation Double centrifugation P criterion
The number of studied samples 40 40
Gender ratio (M/F) 22/18 22/18
Age (years) 25.3±4.1 25.3±4.1
Leukocyte count (×109/l) 6.37±1.67 6.14±1.82 0.561
The number of red blood cells (×1012/l) 4.54±0.71 4.23±0.68 0.826
Platelet Count (×109/l) 228±45.4 243±38.2 0.694
Platelet concentration in the final substrate of platelet-rich plasma is the main indicator of 
the effectiveness of harvesting. Data comparing the concentration of platelets in the resulting sub-
strate with different modes of centrifugation are shown visually (Fig. 1). These data demonstrate 
the advantage of the centrifuging mode 150 g × 15 min with a significant (p<0.05) increase in the 
platelet level higher in comparison with the groups 100 g × 15 min, 150 g × 10 min, 200 g × 10 min, 
200 g × 15 min. Thus, the fundamentally lower efficiency of the 100g modes is demonstrated due 
to the fact that this acceleration under the conditions of our study demonstrated the inconsistency 
of concentration, namely, probably due to the insufficient difference in the sedimentation rate of the 
erythrocyte and buffer layers. On the other hand, an increase in centrifugation rate with an increase 
in centrifugal acceleration up to 200 g also demonstrates a slight decrease in efficiency. With a 
further increase in acceleration to 400 g, we observed a significant decrease in the concentration 
of platelets, which is likely due to their significant damage as well as to the complex hemodynamic 
effects between the erythrocyte and buffer layers in conditions of excessive exposure. Thus, an 
increase in acceleration to 250–400 g at the stage of primary centrifugation is untenable. Results 
close to optimal (150 g × 15 min) were also observed in the 150 g × 20 min group; however, this 
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modification, in comparison with the optimal one, carries only additional time costs without show-
ing advantages.
Comparing the efficiency of platelet concentration in single and double centrifugation pro-
tocol, we reliably noted the advantage of the double protocol (p=0.013) compared to the single pro-
tocol in those modes that were rated as optimal. Differences lose statistical significance in groups 
of 100 g, 200 g.
Fig. 1. Platelet concentration in the resulting PRP substrate in centrifugal modes: 100 g × 15 min, 
150 g × 10 min, 150 g × 15 min, 150 g × 20 min, 200 g × 10 min, 200 g × 15 min. With single and 
double (with the addition of 250 g × 10 min) centrifugation
Analyzing the platelet number multiplication indicator fully confirms the results out-
lined above with respect to platelet concentration. This similarity of results can be explained, in-
cluding the close homogeneity of the groups of studied samples. Similarly, the advantage of the 
150 g × 15 min protocol is demonstrated among all protocols of a single centrifugation as well as a 
150 g × 15 min + 250 g × 10 min protocol from the general number of observations with a reliable 
statistical advantage (p<0/05) (Fig. 2).
Fig. 2. Platelet multiplication factor: in the resulting PRP substrate in centrifugal modes:  
100 g × 15 min, 150 g × 10 min, 150 g × 15 min, 150 g × 20 min, 200 g × 10 min, 200 g × 15 min. 
With single and double (with the addition of 250 g × 10 min) centrifugation.
One of the available criteria for assessing the correctness of the separation of layers when 
performing harvesting is an estimate of the number of erythrocytes or hemoglobin level in the 
final PRP substrate (Fig. 3). Some authors note the high significance of this criterion, while others 
state its low importance, including this indicator may vary coordinately depending on the technical 
features of the selection procedure for the separated layers, the experience of the performer as well 
as the use of various systems. According to our observations, the minimum level of red blood cell 
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concentration was reached in the centrifuging mode 200 g × 10 min. Optimal in terms of platelet 
count, a mode of 150 g × 15 min + 250 g × 10 min demonstrates significantly (p<0.05) a higher level 
of red blood cell concentration. 
Fig. 3. RBC content in the resulting PRP substrate in centrifuging modes:  
100 g × 15min, 150 g × 10 min, 150 g × 15 min, 150 g × 20 min, 200 g × 10 min, 200 g × 15 min. 
With single and double (with the addition of 250 g × 10 min) centrifugation
The concentration of leukocytes in the PRP substrate can also be regarded in two ways. Ac-
cording to the data of various authors, both positive and negative effects of increased leukocyte con-
centration in PRP are evaluated and in many respects such an assessment depends on the objectives 
of the use of the substrate. We can state that the level of leukocytes in the centrifuging mode of 
150 g × 15 min + 250 g × 10 min does not exceed the permissible limits (Fig. 4.). Also, the dynamics 
of the concentration of leukocytes in the comparison groups despite the statistical accuracy should 
not be regarded as a decisive factor in the choice of centrifugation. In our opinion, the demonstrated 
significantly lower concentration of leukocytes in the 200 g × 15 min + 250 g × 10 min group can be 
decisive in choosing such a protocol only for narrowly specialized purposes, in cases where introduc-
ing a leukocyte component into PRP will have a significantly negative effect [23].
Fig. 4. The content of leukocytes in the resulting PRP substrate in centrifuging modes:  
100 g × 15 min, 150 g × 10 min, 150 g × 15 min, 150 g × 20 min, 200 g × 10 min, 200 g × 15 min. 
With single and double (with the addition of 250 g × 10 min) centrifugation
5. Discussion
Analyzing the data from earlier publications, it can be concluded that various authors have 
radically differently evaluated similar centrifugation protocols and also demonstrated radically 
different protocols as optimal for a harvester in completely equal conditions, which maintains the 
relevance and interest in this topic.
A study by Baussetetal [19] demonstrated that centrifugation at 250 g × 15 min, which is 
less commonly used today. A possible reason may be that the centrifugal conditions have a nega-
tive effect, including on platelet activity. During the first centrifugation, Baussetetal (10), namely 
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130 g × 15 min, shows similar data with the one proposed by us [15]. The results of this study 
showed that the first rotation at 150 g × 15 min captured more platelets, in comparison with the 
control groups, which corresponds to the data of Baussetetal.
The level of erythrocytes determined by us corresponds to the permissible limits, which 
confirms the consistency of the technology of centrifugation in syringe containers and also the 
technology of selection of separated layers through aspiration with a syringe manually under visual 
control through a three-way valve Diskofiks S.
The quantitative assessment of the proposed technology of centrifugation and phase selec-
tion with a certain optimal centrifugation protocol demonstrates a high level of efficiency, which is 
not inferior to ready-made solutions proposed on the market [24].
In our opinion, the level of red blood cells to a lesser extent affects the choice of the mode of 
centrifugation. A certain level of leukocytes in the resulting substrate demonstrates a significantly 
lower level in the conditions of centrifugation of 250 g × 15 min which can be regarded as a signif-
icant factor in modifying the procedure in the case of a clinical task in which the leukocyte buffer 
can have a negative effect, otherwise in the majority of cases leukocyte concentration to a lesser 
extent affects the choice of the mode of centrifugation during harvesting.
6. Conclusions
1. Harvesting technique of whole blood with obtaining platelet-rich plasma demonstrat-
ed its viability with regard to the analysis of the quantitative characteristics imposed on the 
substrate.
2. According to the results of the study, the double centrifugation mode 150 g × 15 min + 
+ 250 g × 10 min was determined as the optimal one.
3. Dual centrifugation protocol reliably demonstrated an advantage over a single one.
4. In order to minimize leukocyte buffer in the substrate, the protocol 250 g × 15 min + 
+ 250 g × 10 min can be recommended.
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